Clinical trial
The Effect of Gluten-free Diet on Clinical Symptoms, Immune Parameters and Metabolome in Neurodegenerative Diseases With Alfa-synucleinopathy
NCT05238545 is registered in ClinicalTrials.gov with General University Hospital, Prague as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Gluten-free Diet on Clinical Symptoms, Immune Parameters and Metabolome in Neurodegenerative Diseases With Alfa-synucleinopathy
- Lead sponsor
- General University Hospital, Prague
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 1, 2021
- Completion date
- December 31, 2025
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
multiple system atrophy, non-celiac gluten sensitivity, parkinson disease